Completeness of Schedules. Other than the Summit Patent Rights set forth on Schedule 1.89, Summit does not Control any Patent Rights that Cover any Collaboration Compound or Licensed Product.
Appears in 2 contracts
Sources: License and Collaboration Agreement (Sarepta Therapeutics, Inc.), License and Collaboration Agreement (Summit Therapeutics PLC)